6533b861fe1ef96bd12c5aec

RESEARCH PRODUCT

MORT1/FADD is involved in liver regeneration

Andrea KargPeter R. GalleJürgen BurgJürgen SieblerJ. F. Garcia-lazaroMarcus SchuchmannDavid WallachEugene VarfolomeevAnsgar W. LohseNatalia KnorrWolfgang SchreiberFelix Rückert

subject

Malemedicine.medical_specialtyFas-Associated Death Domain Proteinmedicine.medical_treatmentTransgeneCyclin AApoptosisMice TransgenicCyclin AMiceInternal medicinemedicineAnimalsHepatectomyFADDAdaptor Proteins Signal TransducingCell ProliferationbiologyInterleukin-6GastroenterologyGeneral MedicineFas receptorMolecular biologyPeptide FragmentsLiver regenerationLiver RegenerationBlotBasic ResearchEndocrinologyApoptosisbiology.proteinHepatectomy

description

AIM: To explore the role of the adaptor molecule in liver regeneration after partial hepatectomy (PH). METHODS: We used transgenic mice expressing an N-terminal truncated form of MORT1/FADD under the control of the albumin promoter. As previously shown, this transgenic protein abrogated CD95- and CD120a-mediated apoptosis in the liver. Cyclin A expression was detected using Western blotting. ELISA and RT-PCR were used to detect IL-6 and IL-6 mRNA, respectively. DNA synthesis in liver tissue was measured by BrdU staining. RESULTS: Resection of 70% of the liver was followed by a reduced early regenerative response in the transgenic group at 36 h. Accordingly, 36 h after hepatectomy, cyclin A expression was only detectable in wild-type animals. Consequently, the onset of liver mass restoration was retarded as measured by MRI volumetry and mortality was significantly higher in the transgenic group. CONCLUSION: Our data demonstrate for the first time an involvement of the death receptor molecule MORT1/FADD in liver regeneration, beyond its well described role as part of the intracellular death signaling pathway.

https://doi.org/10.3748/wjg.v11.i46.7248